The investment-grade notes are due 2030 and 2035

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering by Cardinal Health, Inc. of $600 million aggregate principal amount of its 4.500% notes due 2030 and $400 million aggregate principal amount of its 5.150% notes due 2035. The proceeds will fund a portion of the consideration payable in connection with Cardinal Health, Inc.’s acquisition of Solaris Health.

Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions.

The Davis Polk capital markets team included partner John B. Meade and counsel Jennifer (Ying) Lan. Partner James I. McClammy provided litigation advice. Counsel Christopher A. Baratta and associate Georgianna Eck provided tax advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post